Top Tech Companies (2,065)
Don't see your company?
Create a company profile
Tilda Research, based in San Francisco, is an innovator in clinical research execution. We focus on data integration, site-wide automation and real-time operational metrics to enable faster bench-to-market solutions for our research partners. We operate a growing network of clinical research sites in the US, and our team has worked on over 250 pan-indication Phase I thru IV studies.
Diatherix Laboratories provides clinical laboratory services for the detection of infectious disease pathogens.
BRIOTECH HOCl is a globally-focused disruptive supplier of pure HOCl and deployable remotely controlled factories for community empowerment. We produce a pure HOCl from saltwater re-synthesis that has been shown to be a virtual bio mimic of the body’s own defense system (phagocytosis in white blood cells). HOCl stops replication of virtually all pathogens without creation of resistance & persistence mechanisms (superbugs). BrioHOCl solution was tested by NIH on the world’s worst pathogens (all prion species) resulting in unprecedented results for inactivation efficacy while maintaining lasting shelf stability and consistent safety profiles. BRIOTECH has never wavered from its focus on what HOCl products can do for the good of mankind, in all aspects of health and wellness, and the company’s intent is to ensure a lasting, beneficial impact on as many people as possible throughout the world by delivering improvements to their daily lives from use of superior, pure, stable, safe and right-priced HOCl products. Applications and compendiums of scientific supporting data will be available in our comprehensive HOCl Codex, “The Handbook of HOCl” summer 2021. BRIOTECH’s unique credentials, strategic management and technical team have raised the company’s status to become an industry leader in the world of HOCl. More information is available at brioglobal.com As a profit-for-purpose company, 5% of its gross sales are dedicated to underserved populations, with a focus on “at risk women, children and indigenous people” through our foundation, BrioEarth
Mission Bio is a company of passionate people dedicated to solving complex biological problems with precision engineering, innovative biochemistry, and supported bioinformatics. In 2014, the company was spun out of Adam Abate’s lab for high-throughput biology at the University of California, San Francisco (UCSF). Mission Bio’s precision genomics platform is based on the pioneering droplet microfluidics work of Abate and his team. Our mission is to help researchers and clinicians unlock single-cell biology to enable the discovery, development, and delivery of precision medicine. Visit missionbio.com to learn more.
Cyrcadia Health develops a breast health screening device and method based on disruptive technology and tissue health science.
Frontage Laboratories, Inc. is a CRO that provides integrated, science-driven, product development services throughout the drug discovery and development process to enable pharmaceutical and biotechnology companies to achieve their development goals. Comprehensive services include drug metabolism and pharmacokinetics, analytical testing and formulation development, preclinical and clinical trial material manufacturing, bioanalysis, preclinical safety and toxicology assessment and early phase clinical studies. Frontage has enabled many biotechnology companies and leading pharmaceutical companies of varying sizes to advance a myriad of molecules through development and file regulatory submissions in the United States, China and other countries.
Kyverna is a cell therapy company engineering and developing a new class of curative living medicines for inflammatory and autoimmune diseases. Using its SmarTcell™ approach which includes synReg-T cell and synNotch CAR-T technology platforms, Kyverna reprograms T cells to target and selectively suppress or eliminate autoreactive immune cells. The company’s goal is to develop therapies that are selective, potent and durable to tame autoimmunity. We build interdisciplinary teams that bring a broad range of experiences and scientific expertise together to develop medicines that will free patients from the siege of autoimmune diseases and bring curiosity for exploring and creating the unknown. Our commitment to our employees is to foster an open, supportive, and inclusive environment where we create opportunities for individuals to learn and grow to their full potential at every level. synNotch is a trademark of Gilead/Kite.
OcuSciences is developing a technique, flavoprotein fluorescence (FPF), and device to detect and monitor retinal metabolic dysfunction.
Refocus Group is a medical device company engaged in the research and development of treatments for human vision disorders.
FierceMedicalDevices provides breaking news and critical insights into the medical device and diagnostics industries.
Arc Machines, Inc. (AMI), designs, manufactures and distributes state-of-the-art and highly sophisticated automated orbital welding equipment for the power generation, oil & gas, semiconductor, aerospace, high purity, and other industries. Founded in 1976, AMI is headquartered in Pacoima, CA with offices in Houston, TX, Switzerland, Germany, UK, and India. An expansive network of domestic and international representatives allows AMI to sell and support equipment around the world. AMI offers complete products and welding solutions for: Aerospace Nuclear Heat Engineering Manufacturing Vessel Manufacturing Power Generation Semiconductor Shipbuilding Vessel Manufacturing Wastewater Treatment Offshore Petrochemical Fossil Pharmaceutical/Biotechnology/Medical Pulp/Paper Food/Dairy/Beverage One-of-a-kind Industries AMI is not only a leader in designing and manufacturing orbital welding equipment but is also a global solutions provider for all welding-related automation. Recognizing the demand increase for zero defects welding and the rapidly expanding sophistication and complexity of automated welding applications, AMI is dedicated to supporting every aspect of automated welding, machining, robotics, and process development. AMI offers comprehensive and innovative design, implementation, and support to take your next project from concept to completion!
Chemistry is the key to drug discovery, but chemical data is stuck in the twentieth century. We’re generating precise chemical datasets purpose-built to propel drug discovery into the information age — and we’re doing it on a larger scale and faster than has ever before been possible. Terray Therapeutics is a biotechnology company led by pioneers and long-time leaders in artificial intelligence, synthetic (medicinal) chemistry, biology and preclinical development, automation, and nanotechnology. Chemical datasets generated using our novel ultra-dense microarray technology work seamlessly with our integrated machine learning and computational platform to systematically map biochemical interactions between small molecules and causes of disease. Iterative cycles of virtual molecular design and experimentation power AI and machine learning models, which in turn guide the next cycle of design. With a chemistry engine that measures billions of interactions daily and becomes increasingly precise with every cycle, we can answer an unprecedented array of questions — deriving insights that enable us to predictably create drugs for patients in need.
Biolytx Pharmaceuticals developing a drug focused on promoting wound healing and killing antibiotic resistant bacteria.
Peptilogics is an early stage biotech developing a breakthrough technology platform in the antimicrobial segment.
Aggredyne is a biomedical company developing diagnostic devices for platelet therapy.
KeriCure is a biotech company with a platform nanopolymer technology applicable in all areas of skin and wound care
Pernix Therapeutics develops and markets branded and generic pharmaceutical products for the pediatric market.
Immunochemistry Technologies is a strong business with an international distributor network.
.jpg)
Frontier Science is a not-for-profit research organization founded by distinguished Harvard professor Dr. Marvin Zelen in 1975, now known internationally as a trusted data management and statistical center. We collaborate with universities, research networks, pharmaceutical companies, and other industry organizations in all phases of clinical trials and health research.
At Accuray, we make a direct and powerful impact on the lives of cancer patients every day — helping them live longer, better lives. But our commitment to innovation offers a truly unique opportunity: the chance to change the fight against cancer — helping to develop, introduce and support new treatment delivery systems and software that will give new hope and new health to cancer patients and cancer survivors around the world. Accuray develops, manufactures and sells radiotherapy systems for alternative cancer treatments. Our radiation therapy for cancer makes treatment shorter, safer, personalized and more effective, ultimately enabling patients to live longer, better lives.
